Seeding the next wave of myeloma drug development

The Myeloma Investment Fund is putting its own spin on the venture philanthropy model — providing modest amounts of start-up capital, but with a deep knowledge base related to drug development and KOLs that can help newcos develop their myeloma therapies.

The Multiple Myeloma Research Foundation (MMRF) launched the Myeloma Investment Fund (MIF) in 2019 with $50 million to invest in start-up and early-stage companies that have a therapeutic program with the potential to treat MM. ...